drugset / Trial / NCT06632574
A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, dose-escalation and expansion, cohort expansion, multicenter Phase I clinical study in patients with advanced solid tumors.
Timeline
- Start
- 2014-03-19
- Primary completion
- 2025-10-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 33 mg/m2 | Other |
| Subject | Paclitaxel | Small molecule | 66 mg/m2 | Other |